Your browser doesn't support javascript.
loading
The feasibility of a multidimensional intervention in lymphoma survivors with chronic fatigue.
Bøhn, Skh; Oldervoll, L M; Reinertsen, K V; Seland, M; Fosså, A; Kiserud, C; Skaali, T; Nilsen, T S; Blomhoff, R; Henriksen, H B; Lie, H C; Berge, T; Fjerstad, E; Wisløff, T; Slott, M; Zajmovic, I; Thorsen, L.
Afiliación
  • Bøhn S; National Advisory Unit for Late Effects After Cancer Treatment, Department of Oncology, Oslo University Hospital, Radiumhospitalet, Oslo, Norway. synn@ous-hf.no.
  • Oldervoll LM; Centre for Crisis Psychology, Faculty of Psychology, University of Bergen, Bergen, Norway.
  • Reinertsen KV; Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.
  • Seland M; National Advisory Unit for Late Effects After Cancer Treatment, Department of Oncology, Oslo University Hospital, Radiumhospitalet, Oslo, Norway.
  • Fosså A; Department of Clinical Service, The Cancer Rehabilitation Center, Aker, Oslo University Hospital, Oslo, Norway.
  • Kiserud C; National Advisory Unit for Late Effects After Cancer Treatment, Department of Oncology, Oslo University Hospital, Radiumhospitalet, Oslo, Norway.
  • Skaali T; National Advisory Unit for Late Effects After Cancer Treatment, Department of Oncology, Oslo University Hospital, Radiumhospitalet, Oslo, Norway.
  • Nilsen TS; Department of Clinical Service, The Cancer Rehabilitation Center, Aker, Oslo University Hospital, Oslo, Norway.
  • Blomhoff R; Institute of Physical Performance, Norwegian School of Sports Sciences, Oslo, Norway.
  • Henriksen HB; Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
  • Lie HC; Department of Clinical Service, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.
  • Berge T; Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
  • Fjerstad E; Department of Behavioural Medicine, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Wisløff T; Diakonhjemmet Hospital, Oslo, Norway.
  • Slott M; Diakonhjemmet Hospital, Oslo, Norway.
  • Zajmovic I; Health Services Research Unit, Akershus University Hospital, Lørenskog, Norway.
  • Thorsen L; Department of Clinical Service, The Cancer Rehabilitation Center, Aker, Oslo University Hospital, Oslo, Norway.
Support Care Cancer ; 32(1): 22, 2023 Dec 14.
Article en En | MEDLINE | ID: mdl-38095797
ABSTRACT

PURPOSE:

Chronic fatigue (CF) affects 25-30% of lymphoma survivors, but interventions designed to reduce fatigue are lacking. The main aim of this study was to test the feasibility of a multidimensional intervention study in lymphoma survivors with CF. Secondary aims were to describe individual changes in fatigue, quality of life (QoL) and physical performance from pre (T0) to post (T1) intervention.

METHODS:

This feasibility study was as a one-armed intervention study performed in 2021. Hodgkin or aggressive non-Hodgkin lymphoma survivors received mailed study information and Chalder Fatigue Questionnaire and were asked to respond if they suffered from fatigue. The 12-week intervention included patient education, physical exercise, a cognitive behavioural therapy (CBT)-based group program and nutritional counselling. Feasibility data included patient recruitment, completion of assessments, adherence to the intervention and patient-reported experience measures. Participants responded to questionnaires and underwent physical tests at T0 and T1.

RESULTS:

Seven lymphoma survivors with CF were included. Of all assessments, 91% and 83% were completed at T0 and T1, respectively. Adherence to the interventional components varied from 69% to 91%. At T1, all participants rated exercise as useful, of whom five rated the CBT-based program and five rated individual nutritional counselling as useful. Five participants reported improved fatigue, QoL and physical performance.

CONCLUSION:

Lymphoma survivors with CF participating in a multidimensional intervention designed to reduce the level of fatigue showed high assessment completion rate and intervention adherence rate. Most of the participants evaluated the program as useful and improved their level of fatigue, QoL and physical performance after the intervention. TRIAL REGISTRATION ClinicalTrials.gov, identifier NCT04931407. Registered 16. April 2021-Retrospectively registered. https//www. CLINICALTRIALS gov/ct2/show/NCT04931407.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Síndrome de Fatiga Crónica Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Síndrome de Fatiga Crónica Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article